<?xml version='1.0' encoding='utf-8'?>
<container xmlns="https://open.law/schemas/library" xmlns:cache="https://open.law/schemas/cache" xmlns:citations="https://open.law/schemas/citations" xmlns:macro="https://open.law/schemas/macro" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsl="http://www.w3.org/1999/XSL/Transform" xmlns:codified="https://open.law/schemas/codified" xmlns:codify="https://open.law/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude">
  <prefix>Chapter</prefix>
  <num>21</num>
  <heading>Pharmacists</heading>
  <section>
    <prefix>Regulation</prefix>
    <num>.01</num>
    <heading>Purpose and Scope.</heading>
    <text>This chapter establishes requirements for individual pharmacists who enroll in the Program.</text>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.02</num>
    <heading>Definitions.</heading>
    <para>
      <num>A.</num>
      <text>In this chapter, the following terms have the meanings indicated.</text>
    </para>
    <para>
      <num>B.</num>
      <text>Terms Defined.</text>
      <para>
        <num>(1)</num>
        <text>“Board” means the Maryland Board of Pharmacy.</text>
      </para>
      <para>
        <num>(2)</num>
        <text>“Maryland Medical Assistance Program” means the program of comprehensive medical and other health-related care for indigent and medically indigent individuals.</text>
      </para>
      <para>
        <num>(3)</num>
        <text>“Medication therapy management” services are defined as face-to-face consultations that are structured to reduce the risk of adverse events and ensure optimum therapeutic outcomes for targeted patients through improved medication use with disease-state specific education, counseling, and medication review related to treatments, including drug therapy, laboratory tests, or medical devices provided by licensed and practicing pharmacists.</text>
      </para>
      <para>
        <num>(4)</num>
        <text>“Participant” means an individual who is certified as eligible for, and is receiving, Medical Assistance benefits.</text>
      </para>
      <para>
        <num>(5)</num>
        <text>“Pharmacist” means an individual licensed in good standing to practice pharmacy in the state where the service is provided.</text>
      </para>
      <para>
        <num>(6)</num>
        <text>“Program” means the Maryland Medical Assistance Program.</text>
      </para>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.03</num>
    <heading>Provider Qualifications and Conditions for Participation.</heading>
    <text>The pharmacist shall meet:</text>
    <para>
      <num>A.</num>
      <text>Licensure requirements set forth in <cite path="10.09.36.02">COMAR 10.09.36.02</cite>;</text>
    </para>
    <para>
      <num>B.</num>
      <text>Conditions for participation set forth in <cite path="10.09.36.03">COMAR 10.09.36.03</cite>; and</text>
    </para>
    <para>
      <num>C.</num>
      <text>Conditions for their license under the Board of Pharmacy as stated in <cite doc="Md. Code" path="gho">Health Occupations Article, Title 12, Subtitle 3, Annotated Code of Maryland</cite>.</text>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.04</num>
    <heading>Covered Services.</heading>
    <text>The Program covers the following medically necessary services when rendered by a pharmacist:</text>
    <para>
      <num>A.</num>
      <text>Services rendered within the pharmacist’s lawful scope of practice as defined by the Board and otherwise covered by the Program in accordance with <cite path="10.09.02.07|D.">COMAR 10.09.02.07D</cite>; and</text>
    </para>
    <para>
      <num>B.</num>
      <text>Medication therapy management for participants who meet the Department’s clinical criteria.</text>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.05</num>
    <heading>Limitations.</heading>
    <text>The following are not covered:</text>
    <para>
      <num>A.</num>
      <text>Pharmacist administered drugs obtained from manufacturers who do not participate in the federal Drug Rebate Program;</text>
    </para>
    <para>
      <num>B.</num>
      <text>Medical supplies usually included in an office visit;</text>
    </para>
    <para>
      <num>C.</num>
      <text>Services not medically necessary;</text>
    </para>
    <para>
      <num>D.</num>
      <text>Investigational and experimental drugs and procedures;</text>
    </para>
    <para>
      <num>E.</num>
      <text>Procedures solely for cosmetic purposes; and</text>
    </para>
    <para>
      <num>F.</num>
      <text>Services denied by Medicare as not medically justified.</text>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.06</num>
    <heading>Payment Procedures.</heading>
    <para>
      <num>A.</num>
      <text>The provider shall adhere to general provider payment procedures established in <cite path="10.09.36.04">COMAR 10.09.36.04</cite>.</text>
    </para>
    <para>
      <num>B.</num>
      <text>The provider shall be reimbursed in accordance with <cite path="10.09.02.07|D.">COMAR 10.09.02.07D</cite>.</text>
    </para>
    <para>
      <num>C.</num>
      <text>Effective January 1, 2024, medication therapy management shall be reimbursed at the following rates:</text>
      <para>
        <num>(1)</num>
        <text>For the first 8—15 minutes:</text>
        <para>
          <num>(a)</num>
          <text>For new patients, $49.67 per unit of service; or</text>
        </para>
        <para>
          <num>(b)</num>
          <text>For established patients, $31.24 per unit of service; and</text>
        </para>
      </para>
      <para>
        <num>(2)</num>
        <text>For each additional 8—15 minute, $24.54 per unit of service.</text>
      </para>
    </para>
    <para>
      <num>D.</num>
      <text>Billing time limitations for claims submitted pursuant to this chapter are set forth in <cite path="10.09.36.06">COMAR 10.09.36.06</cite>.</text>
    </para>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.07</num>
    <heading>Recovery and Reimbursement.</heading>
    <text>Recovery and reimbursement are as set forth in <cite path="10.09.36.07">COMAR 10.09.36.07</cite>.</text>
    <annotations/>
  </section>
  <section>
    <prefix>Regulation</prefix>
    <num>.08</num>
    <heading>Cause for Suspension or Removal and Imposition of Sanctions.</heading>
    <text>Causes for suspension or removal and imposition of sanctions are as set forth in <cite path="10.09.36.08">COMAR 10.09.36.08</cite>.</text>
    <annotations/>
  </section>
  <annotations>
    <annotation type="Authority" dest="container">Health-General Article, §§2-104(b), 2-105(b), 15-103, and 15-148(c), Annotated Code of Maryland</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2018-12-31">Effective date: December 31, 2018 (45:26 Md. R. 1242)</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2025-01-06"><cite path="|10|09|21|.02|B.">Regulation .02B</cite> amended effective May 1, 2023 (50:8 Md. R. 337); January 6, 2025 (51:26 Md. R. 1187)</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2025-01-06"><cite path="|10|09|21|.03">Regulation .03</cite> amended effective January 6, 2025 (51:26 Md. R. 1187)</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2023-05-01"><cite path="|10|09|21|.03|C.">Regulation .03C</cite>, D adopted effective May 1, 2023 (50:8 Md. R. 337)</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2025-01-06"><cite path="|10|09|21|.04">Regulation .04</cite> amended effective May 1, 2023 (50:8 Md. R. 337); January 6, 2025 (51:26 Md. R. 1187)</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2025-01-06"><cite path="|10|09|21|.05">Regulation .05</cite> amended effective January 6, 2025 (51:26 Md. R. 1187)</annotation>
    <annotation type="History" subtype="Administrative History" dest="container" effective="2025-01-06"><cite path="|10|09|21|.06">Regulation .06</cite> amended effective June 14, 2021 (48:12 Md. R. 473); May 1, 2023 (50:8 Md. R. 337); January 6, 2025 (51:26 Md. R. 1187)</annotation>
  </annotations>
</container>
